Janssen (BetaLogics) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Janssen (BetaLogics) General Information

Description

Developer of transformational stem cell therapy to treat diabetes. The company is developing stem cell-derived therapy for diabetes treatment and to eliminate a need for exogenous insulin.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Horsham, PA
  • United States
Primary Industry
Biotechnology
Acquirer
ViaCyte
Vertical(s)
Life Sciences
Corporate Office
  • Horsham, PA
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Janssen (BetaLogics) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Janssen (BetaLogics)‘s full profile, request access.

Request a free trial

Janssen (BetaLogics) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Janssen (BetaLogics)‘s full profile, request access.

Request a free trial

Janssen (BetaLogics) FAQs

  • Where is Janssen (BetaLogics) headquartered?

    Janssen (BetaLogics) is headquartered in Horsham, PA.

  • What industry is Janssen (BetaLogics) in?

    Janssen (BetaLogics)’s primary industry is Biotechnology.

  • Is Janssen (BetaLogics) a private or public company?

    Janssen (BetaLogics) is a Private company.

  • What is Janssen (BetaLogics)’s current revenue?

    The current revenue for Janssen (BetaLogics) is 000000.

  • Who are Janssen (BetaLogics)’s investors?

    Ortho-McNeil Pharmaceuticals has invested in Janssen (BetaLogics).

  • When was Janssen (BetaLogics) acquired?

    Janssen (BetaLogics) was acquired on 18-Dec-2015.

  • Who acquired Janssen (BetaLogics)?

    Janssen (BetaLogics) was acquired by ViaCyte.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »